STOCK TITAN

Crexendo (CXDO) SEC Filings, Mar 5-6, 2026

CXDO NASDAQ

Crexendo, Inc. filings document the formal disclosure record for its cloud communications and UCaaS software business. Recent Form 8-K reports include financial results furnished with service, software solutions and product revenue categories, operating expense metrics, net income, EBITDA and adjusted EBITDA measures.

The filing record also covers material corporate events and governance matters, including the completed acquisition of Estech Systems, LLC, a credit agreement with revolving and term-loan facilities, annual meeting voting results, director elections, advisory compensation votes, and Regulation FD investor-presentation disclosures. These filings describe Crexendo's financing arrangements, capital actions, shareholder approvals, governance structure and operating performance as a public software technology company.

Rhea-AI Summary

Crexendo, Inc. director David Roy Williams reported receiving a grant of stock options. The award covers 10,000 stock options with an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the director earns the right to exercise a portion of the options each month over three years. Following this grant, Williams is shown as holding 10,000 stock options directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Rhea-AI Summary

Crexendo, Inc. director Anil K. Puri reported receiving a grant of stock options for 10,000 shares at an exercise price of $6.47 per share. This is an acquisition of derivative securities rather than an open-market stock purchase.

The options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years, aligning Puri’s potential equity ownership with longer-term service to the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Rhea-AI Summary

Crexendo, Inc. director Kevin Arnold Jackson reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, giving him the right to buy company stock at that price in the future.

According to the filing, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years rather than all at once. After this grant, he holds 10,000 stock options directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
Rhea-AI Summary

Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, all held as direct ownership. The options vest over 36 equal monthly installments beginning on April 4, 2026, meaning the right to exercise builds gradually over three years rather than all at once.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Rhea-AI Summary

Crexendo, Inc. director and major shareholder Steven G. Mihaylo reported receiving a grant of stock options. The award covers 10,000 stock options at an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments starting on April 4, 2026, meaning the grant becomes exercisable gradually over three years rather than all at once.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
current report
Rhea-AI Summary

Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported routine equity award activity. On March 4 and 5, 2026, he exercised restricted stock units, receiving a total of 5,001 shares of common stock at a price of $0.00 per share through derivative conversions.

To cover associated payroll taxes, the company withheld 868 shares at $6.47 on March 4 and 1,193 shares at $6.88 on March 5, which footnotes state do not represent sales by him. After these transactions, he directly owned 650,431 shares of Crexendo common stock. Footnotes also describe RSU grants that vest quarterly over 12 quarters beginning in 2024, 2025, and 2026, contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Rhea-AI Summary

Crexendo, Inc. Chief Revenue Officer Jon Brinton reported multiple equity compensation transactions. On March 4, 2026, he received a grant of 40,000 Restricted Stock Units (RSUs), which will vest in equal quarterly installments over 12 quarters starting on June 4, 2026, subject to continuous employment, with shares delivered upon vesting.

Brinton also exercised RSUs into common stock on March 4 and 5, 2026, converting 2,916 and 2,917 RSUs, respectively, into the same number of common shares at no exercise price. To cover associated payroll taxes, the company withheld 923 shares at $6.47 on March 4 and 843 shares at $6.88 on March 5; footnotes state these withholdings do not represent sales by Brinton. After these transactions, he directly held 124,795 shares of common stock and RSU awards as reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
-
Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Gaylor Douglas Walter reported several equity compensation transactions. On March 4 and 5, 2026, he exercised multiple restricted stock unit (RSU) awards, converting them into shares of Crexendo common stock, including blocks of 70,000, 5,000, and 4,167 units.

In connection with these vested RSUs, the company withheld 1,368, 76, and 1,140 shares of common stock at prices of $6.47 and $6.88 per share to pay associated payroll taxes. Footnotes state these withholding transactions do not represent open‑market sales by the executive. Following the latest transactions, he directly owned 270,206 shares of Crexendo common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider
Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported multiple equity compensation transactions involving restricted stock units (RSUs) and common stock. On March 4, 2026, he received a grant of 70,000 RSUs, which the footnotes state will vest in equal monthly installments over 36 months starting on March 4, 2026, with shares delivered upon vesting.

He also exercised previously awarded RSUs into common stock on March 4 and March 5, 2026, at a stated price of $0.00 per share, increasing his direct common share holdings. Following the last reported transaction on March 5, 2026, he directly owned 179,869 shares of Crexendo common stock.

On both dates, the company withheld portions of his common shares—1,368 shares at $6.47 and 1,140 shares at $6.88—to cover associated payroll taxes. The footnotes clarify that these tax-withholding transactions do not represent open-market sales by the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
insider

FAQ

How many Crexendo (CXDO) SEC filings are available on StockTitan?

StockTitan tracks 178 SEC filings for Crexendo (CXDO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Crexendo (CXDO)?

The most recent SEC filing for Crexendo (CXDO) was filed on March 6, 2026.